InvoCare share price rises on acquisitions announcement

The InvoCare Ltd (ASX: IVC) share price is one to watch in early trade after two new acquisitions from the Aussie funeral operator.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The InvoCare Limited (ASX: IVC) share price is one to watch this morning after the company's latest acquisition update.

a woman

What did InvoCare announce this morning?

The Aussie funeral company has entered into 2 separate sales agreements for business on the southern New South Wales coast.

InvoCare will acquire the business and assets of Batemans Bay and Moruya District Funerals as well as Broulee Memorial Gardens. The company expects to complete the purchases by the end of November.

The InvoCare share price has already lifted 1.48% in early trade to $13.68 per share.

Batemans Bay & Moruya District Funerals operates from 3 locations in Batemans Bay, Moruya and Narooma. The company performed over 400 funerals every year with annual revenue of $3 million.

Broulee Memorial Gardens performs 380 cremations per year including chapel services and memorialisation.

There was no dollar amount provided by InvoCare in the announcement regarding acquisition cost.

Where is the InvoCare share price headed this morning?

InvoCare shareholders have reacted to the news in early trade this morning, with the company's share price lifting 1.48% at time of writing. Acquirers' shares often trade heavily in the period after announcing an acquisition and this could be the case even with the smaller targets.

The company's shares also closed 0.97% higher on Monday at $13.48 per share as the S&P/ASX 200 Index (INDEXASX: XJO) hit a 3-month high.

How has the InvoCare share price performed this year?

The InvoCare share price has rocketed more than 32% higher so far this year to significantly outperform the ASX 200.

The Aussie funeral home operator has also managed to outpace fellow ASX competitor Propel Funeral Partners Ltd (ASX: PFP). The Propel share price is up 21.12% so far this year as the ASX Healthcare sector has had a strong 2019 performance.

Foolish takeaway

I'd expect to see continued movement from the InvoCare share price during morning trade following this acquisition news.

InvoCare is currently trading at a 36x earnings multiple with a tidy 2.71% net dividend yield.

Motley Fool contributor Kenneth Hall has no position in any of the stocks mentioned. The Motley Fool Australia has recommended InvoCare Limited and Propel Funeral Partners Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A cool white-bearded man holds his hand up signalling you should halt.
Healthcare Shares

ASX 300 cannabis stock Incannex suspended ahead of 'material update'

The Incannex share price is frozen at 14 cents for now.

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

Guess which ASX All Ords stock is rocketing 27% on a new FDA approval

Rett Syndrome has finally got an approved treatment.

Read more »

Five healthcare workers standing together and smiling.
Healthcare Shares

Buy these excellent ASX 200 healthcare shares: Goldman Sachs

Goldman has spoken very positively about these healthcare shares this week.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
Healthcare Shares

Should I buy CSL shares while they're under $300?

Can investors make a healthy return with this biotech?

Read more »

A man wearing a white coat holds his hands up and mouth open with joy.
Healthcare Shares

Mesoblast share price rockets 23% on FDA news

Mesoblast has received some good news for the US FDA this morning.

Read more »

A young woman wearing a blue blouse with white polkadots holds her phone up with an intrigued and happy look on her face as she reads some news.
Healthcare Shares

Owners of this ASX 200 share are soon going to receive a bigger dividend

Investors in this healthcare company are about to get a healthy cash boost.

Read more »

an older couple look happy as they sit at a laptop computer in their home.
Healthcare Shares

Hoping to collect the latest CSL dividend? Here's how

The next CSL dividend is fast approaching.

Read more »